Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 9/20 | 0.61 |
| ▸ | CA12 | O43570 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA3 | P07451 | 2/20 | 0.61 |
| ▸ | CA4 | P22748 | 2/20 | 0.61 |
| ▸ | CA6 | P23280 | 2/20 | 0.61 |
| ▸ | CA5A | P35218 | 2/20 | 0.61 |
| ▸ | CA7 | P43166 | 2/20 | 0.61 |
| ▸ | CA9 | Q16790 | 2/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.61 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28836736 | 1.00 | DNM1 (0.61) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL28431058 | 1.00 | DNM1 (0.61) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL28383397 | 1.00 | DNM1 (0.61) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL345699 | 1.00 | — | — | |
| SCHEMBL3002135 | 1.00 | — | — | |
| SCHEMBL5554848 | 1.00 | DNM1 (0.61) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL19037263 | 1.00 | DNM1 (0.61) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL1695732 | 1.00 | — | — | |
| SCHEMBL4373470 | 1.00 | DNM1 (0.61) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL7516444 | 1.00 | DNM1 (0.61) | DNM1CA12CA1CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119177076-B | High-weather-resistance water-based acrylic polyurethane finish paint and preparation method thereof | 陕西虹瑞化工科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119177076-A | High-weather-resistance water-based acrylic polyurethane finish paint and preparation method thereof | 陕西虹瑞化工科技有限公司 | 2024-12-24 | — | — | CN | claimed |
| US-20250367166-A1 | NEXT GENERATION DIPROVOCIMS THAT ACTIVATE THE INNATE AND ADAPTIVE IMMUNE RESPONSE | SCRIPPS RESEARCH INST (US) | 2025-12-04 | — | — | US | disclosed |
| CN-119177076-B | High-weather-resistance water-based acrylic polyurethane finish paint and preparation method thereof | 陕西虹瑞化工科技有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119177076-B | High-weather-resistance water-based acrylic polyurethane finish paint and preparation method thereof | 陕西虹瑞化工科技有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119177076-A | High-weather-resistance water-based acrylic polyurethane finish paint and preparation method thereof | 陕西虹瑞化工科技有限公司 | 2024-12-24 | — | — | CN | disclosed |
| CN-119177076-A | High-weather-resistance water-based acrylic polyurethane finish paint and preparation method thereof | 陕西虹瑞化工科技有限公司 | 2024-12-24 | — | — | CN | disclosed |
| WO-2023212650-A1 | NEXT GENERATION DIPROVOCIMS THAT ACTIVATE THE INNATE AND ADAPTIVE IMMUNE RESPONSE | THE SCRIPPS RESEARCH INSTITUTE (US) | 2023-11-02 | — | — | WO | disclosed |
| CN-114163641-B | Ammonium polybenzimidazole and alkaline ion exchange membrane thereof, and preparation method and application of ionomer | 大连理工大学 | 2022-09-20 | — | — | CN | disclosed |
| CN-114163641-A | Ammonium polybenzimidazole and alkaline ion exchange membrane thereof, and preparation method and application of ionomer | 大连理工大学 | 2022-03-11 | — | — | CN | disclosed |
| US-10908153-B2 | Pseudomonas aeruginosa inhibitor compounds | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2021-02-02 | — | — | US | disclosed |
| EP-3322421-B1 | PSEUDOMONAS AERUGINOSA INHIBITOR COMPOUNDS | CENTRE NAT RECH SCIENT (FR) | 2020-06-10 | — | — | EP | disclosed |
| US-20180209969-A1 | Pseudomonas Aeruginosa Inhibitor Compounds | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2018-07-26 | — | — | US | disclosed |
| WO-2017009344-A1 | PSEUDOMONAS AERUGINOSA INHIBITOR COMPOUNDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2017-01-19 | — | — | WO | disclosed |
| EP-0882716-B1 | PYRIDINECARBOXAMIDE DERIVATIVES | NISSHIN PHARMA INC (JP) | 2002-04-10 | — | — | EP | disclosed |
| US-6046201-A | Pyridinecarboxamide derivatives | NISSHIN FLOUR MILLING CO., LTD. (JP) | 2000-04-04 | — | — | US | disclosed |
| EP-0882716-A1 | PYRIDINECARBOXAMIDE DERIVATIVES | Nisshin Flour Milling Co., Ltd. (JP) | 1998-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10908153-B2 | Pseudomonas aeruginosa inhibitor compounds | CLPP, SERPINB1, TFPI | DNM1 1024/4885CA12 4700/4885CA1 4880/4885 |
| US-20180209969-A1 | Pseudomonas Aeruginosa Inhibitor Compounds | CLPP, SERPINB1, TFPI | DNM1 1024/4885CA12 4700/4885CA1 4880/4885 |
| US-20250367166-A1 | NEXT GENERATION DIPROVOCIMS THAT ACTIVATE THE INNATE AND ADAPTIVE IMMUNE RESPONSE | TLR1, TLR4, TLR3 | DNM1 883/4885CA12 4538/4885CA1 2685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.